Annual Retained Earnings
-$131.30 M
-$54.37 M-70.66%
December 31, 2023
Summary
- As of February 7, 2025, SPRY annual retained earnings is -$131.30 million, with the most recent change of -$54.37 million (-70.66%) on December 31, 2023.
- During the last 3 years, SPRY annual retained earnings has fallen by -$109.29 million (-496.48%).
- SPRY annual retained earnings is now -496.48% below its all-time high of -$22.01 million, reached on December 1, 2020.
Performance
SPRY Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$173.24 M
-$19.13 M-12.41%
September 30, 2024
Summary
- As of February 7, 2025, SPRY quarterly retained earnings is -$173.24 million, with the most recent change of -$19.13 million (-12.41%) on September 30, 2024.
- Over the past year, SPRY quarterly retained earnings has dropped by -$19.13 million (-12.41%).
- SPRY quarterly retained earnings is now -309.97% below its all-time high of -$42.26 million, reached on December 1, 2021.
Performance
SPRY Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
SPRY Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.7% | -12.4% |
| 3 y3 years | -496.5% | -12.4% |
| 5 y5 years | -496.5% | -12.4% |
SPRY Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -210.7% | at low | -310.0% | at low |
| 5 y | 5-year | -496.5% | at low | -310.0% | at low |
| alltime | all time | -496.5% | at low | -310.0% | at low |
ARS Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$173.24 M(+12.4%) |
| Jun 2024 | - | -$154.11 M(+8.8%) |
| Mar 2024 | - | -$141.59 M(+7.8%) |
| Dec 2023 | -$131.30 M | -$131.30 M(+5.8%) |
| Sep 2023 | - | -$124.14 M(+13.6%) |
| Jun 2023 | - | -$109.27 M(+18.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$91.90 M(+19.4%) |
| Dec 2022 | -$76.94 M(+82.1%) | -$76.94 M(+37.6%) |
| Jun 2022 | - | -$55.93 M(+32.4%) |
| Dec 2021 | -$42.26 M(+92.0%) | - |
| Dec 2021 | - | -$42.26 M |
| Dec 2020 | -$22.01 M | - |
FAQ
- What is ARS Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual retained earnings year-on-year change?
- What is ARS Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly retained earnings year-on-year change?
What is ARS Pharmaceuticals annual retained earnings?
The current annual retained earnings of SPRY is -$131.30 M
What is the all time high annual retained earnings for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual retained earnings is -$22.01 M
What is ARS Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, SPRY annual retained earnings has changed by -$54.37 M (-70.66%)
What is ARS Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of SPRY is -$173.24 M
What is the all time high quarterly retained earnings for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly retained earnings is -$42.26 M
What is ARS Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, SPRY quarterly retained earnings has changed by -$19.13 M (-12.41%)